Data as of Jul 21
| -0.06 / -1.19%|
The 2 analysts offering 12-month price forecasts for Alexza Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 10.00. The median estimate represents a +101.21% increase from the last price of 4.97.
The current consensus among 2 polled investment analysts is to Buy stock in Alexza Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.